>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
: SCVL -13.4%, SOL -7.6%, MTL -5%, FRO -1.7%, MNK -0.5%

Select metals/mining stocks trading lower:
  • HMY -5.3%, SBGL -4.2%, GFI -3.6%, CLF -3.6%, VALE -3.3%, FCX -3%, AU -2.4%, GDX -2%, AG -2%, PAAS -2%, HL-1.8%, ABX -1.8%
  • RIO -1.6%, IAG -1.6%, NEM -1.6%, BHP -1.4%, BBL -1.3%, MT -0.9%, GLD -0.9%
Select oil/gas related names showing early weakness: WLL -2.6%, OAS -2.4%, SDRL -2%, RIG -1.2%, HAL -1.1%,RDS.A -0.8%, CHK -0.8%

Other news:
  • NVLS -54.7% ( Phase 2 trial evaluating efficacy and safety of two doses of cavosonstat failed to demonstrate benefit in absolute change in percent predicted FEV1 or in sweat chloride reduction at 12 weeks)
  • FOLD -26.7% ( announces U.S. regulatory pathway for Migalastat for Fabry Disease)
  • GLBS -7.6% (after stock doubled on Monday)
  • BOJA -6.3% ( announces a 6 mln share underwritten public offering of common stock by selling shareholders )
  • TCBI -3.8% (prices 3.0 mln shares of common stock for gross proceeds of $210.0 mln )
  • COTV -3.5% ( commences 10 mln common stock offering by selling stockholders)
  • BIP -3.5% (light volume; Brookfield Infrastructure announces $750 million equity offering)
  • FDUS -3.4% (commences registered public offering of 2.5 mln shares of common stock through an underwritten public offering)
  • SITE -3.1% (ticking lower; commences 8 mln common stock offering by selling stockholders Clayton, Dubilier & Rice, LLC, and Deere & Company)
Analyst comments:
  • AKS -3.5% (downgraded to Neutral from Outperform at Macquarie)
  • X -3% (downgraded to Hold from Buy at Argus)
  • RS -1.3% (downgraded to Neutral from Outperform at Macquarie)
  • MCD -0.8% (removed from US Focus List at Credit Suisse)